{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2977"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2977","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Utilizing probiotics to reduce diet induced dysbiosis and inflammation in myelodysplastic syndromes susceptible mice","abstract":"Human gut microbiota is helpful in digestion by helping in breaking complex carbohydrates, proteins, fats and fibers and many other physiological functions. The Western diet which is high in fat and carbo hydrate percentage alters gut microbiota and leads to growth of pathogenic bacteria and altered gut flora referred to as dysbiosis, which in turn cause gut inflammation and increased permeability of gut and it causes translocation of Lipopolysaccharides (LPS) which causes low grade systemic inflammation. Disturbance in gut microbiota correlated with metabolic conditions like obesity and leads to progression of hematologic diseases like Myelodysplastic Syndromes (MDS). Myelodysplastic syndromes are a group of diverse bone marrow disorders in which bone marrow does not produce enough healthy blood cells, the blood stem cells do not mature and get accumulated in bone marrow results in fewer than normal mature blood cells referred as cytopenia, which is hallmark of MDS. Moreover, approximately one third of MDS patients also develop AML due to acquisition of additional mutations in the defective hematopoietic stem or progenitor cells (HSPC). Studies have shown that probiotics helps in reducing gut inflammation and maintaining gut barrier. The goal of this study is to establish high fat diet induced effects on gut microbiome in mouse model and to elucidate how probiotics help in mitigating high fat diet induced gut inflammation and which in turn slow down the progression of hematologic malignancies like MDS.","abstract_html":"Human gut microbiota is helpful in digestion by helping in breaking complex carbohydrates, proteins, fats and fibers and many other physiological functions. The Western diet which is high in fat and carbo hydrate percentage alters gut microbiota and leads to growth of pathogenic bacteria and altered gut flora referred to as dysbiosis, which in turn cause gut inflammation and increased permeability of gut and it causes translocation of Lipopolysaccharides (LPS) which causes low grade systemic inflammation. Disturbance in gut microbiota correlated with metabolic conditions like obesity and leads to progression of hematologic diseases like Myelodysplastic Syndromes (MDS). Myelodysplastic syndromes are a group of diverse bone marrow disorders in which bone marrow does not produce enough healthy blood cells, the blood stem cells do not mature and get accumulated in bone marrow results in fewer than normal mature blood cells referred as cytopenia, which is hallmark of MDS. Moreover, approximately one third of MDS patients also develop AML due to acquisition of additional mutations in the defective hematopoietic stem or progenitor cells (HSPC). Studies have shown that probiotics helps in reducing gut inflammation and maintaining gut barrier. The goal of this study is to establish high fat diet induced effects on gut microbiome in mouse model and to elucidate how probiotics help in mitigating high fat diet induced gut inflammation and which in turn slow down the progression of hematologic malignancies like MDS.","abstract_has_math":false,"creators":["Bolloju, Tejaswee"],"institution":null,"degree_name":"Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"School of Pharmacy","degree_department":null,"school":null,"contributors":["Dr. Melinda E. Varney","Dr. Timothy Long","Dr. Jeremy McAleer"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:17Z","subjects":["Medical Pharmacology","Medicine and Health Sciences","Nutritional and Metabolic Diseases","Pharmacy and Pharmaceutical Sciences","Myelodysplastic Syndromes (MDS)","bone marrow disorders","nutrition","gut microbiota"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1972","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1972","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2977","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Melinda E. Varney","Dr. Timothy Long","Dr. Jeremy McAleer"]},{"key":"dc:creator","label":"Author","values":["Bolloju, Tejaswee"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-08-04T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2025-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["School of Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Pharmaceutical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Pharmacology","Medicine and Health Sciences","Nutritional and Metabolic Diseases","Pharmacy and Pharmaceutical Sciences","Myelodysplastic Syndromes (MDS)","bone marrow disorders","nutrition","gut microbiota"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1972"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Human gut microbiota is helpful in digestion by helping in breaking complex carbohydrates, proteins, fats and fibers and many other physiological functions. The Western diet which is high in fat and carbo hydrate percentage alters gut microbiota and leads to growth of pathogenic bacteria and altered gut flora referred to as dysbiosis, which in turn cause gut inflammation and increased permeability of gut and it causes translocation of Lipopolysaccharides (LPS) which causes low grade systemic inflammation. Disturbance in gut microbiota correlated with metabolic conditions like obesity and leads to progression of hematologic diseases like Myelodysplastic Syndromes (MDS). Myelodysplastic syndromes are a group of diverse bone marrow disorders in which bone marrow does not produce enough healthy blood cells, the blood stem cells do not mature and get accumulated in bone marrow results in fewer than normal mature blood cells referred as cytopenia, which is hallmark of MDS. Moreover, approximately one third of MDS patients also develop AML due to acquisition of additional mutations in the defective hematopoietic stem or progenitor cells (HSPC). Studies have shown that probiotics helps in reducing gut inflammation and maintaining gut barrier. The goal of this study is to establish high fat diet induced effects on gut microbiome in mouse model and to elucidate how probiotics help in mitigating high fat diet induced gut inflammation and which in turn slow down the progression of hematologic malignancies like MDS."]},{"key":"dc:title","label":"Title","values":["Utilizing probiotics to reduce diet induced dysbiosis and inflammation in myelodysplastic syndromes susceptible mice"]}]}],"canonical_facts":{"dc:contributor":["Dr. Melinda E. Varney","Dr. Timothy Long","Dr. Jeremy McAleer"],"dc:creator":["Bolloju, Tejaswee"],"dc:date.available":["2026-08-04T07:00:00Z"],"dc:date.created":["2025-01-01T08:00:00Z"],"dc:description.abstract":["Human gut microbiota is helpful in digestion by helping in breaking complex carbohydrates, proteins, fats and fibers and many other physiological functions. The Western diet which is high in fat and carbo hydrate percentage alters gut microbiota and leads to growth of pathogenic bacteria and altered gut flora referred to as dysbiosis, which in turn cause gut inflammation and increased permeability of gut and it causes translocation of Lipopolysaccharides (LPS) which causes low grade systemic inflammation. Disturbance in gut microbiota correlated with metabolic conditions like obesity and leads to progression of hematologic diseases like Myelodysplastic Syndromes (MDS). Myelodysplastic syndromes are a group of diverse bone marrow disorders in which bone marrow does not produce enough healthy blood cells, the blood stem cells do not mature and get accumulated in bone marrow results in fewer than normal mature blood cells referred as cytopenia, which is hallmark of MDS. Moreover, approximately one third of MDS patients also develop AML due to acquisition of additional mutations in the defective hematopoietic stem or progenitor cells (HSPC). Studies have shown that probiotics helps in reducing gut inflammation and maintaining gut barrier. The goal of this study is to establish high fat diet induced effects on gut microbiome in mouse model and to elucidate how probiotics help in mitigating high fat diet induced gut inflammation and which in turn slow down the progression of hematologic malignancies like MDS."],"dc:identifier":["https://mds.marshall.edu/etd/1972"],"dc:subject":["Medical Pharmacology","Medicine and Health Sciences","Nutritional and Metabolic Diseases","Pharmacy and Pharmaceutical Sciences","Myelodysplastic Syndromes (MDS)","bone marrow disorders","nutrition","gut microbiota"],"dc:title":["Utilizing probiotics to reduce diet induced dysbiosis and inflammation in myelodysplastic syndromes susceptible mice"],"thesis:degree_discipline":["School of Pharmacy"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Pharmaceutical Sciences"]},"updated_at":"2026-11-21T19:58:17Z"}